|
IFRX
|
InflaRx N.V.
|
US
|
NASDAQ
|
|
IMGN
|
ImmunoGen, Inc.
|
US
|
NASDAQ
|
|
IMNM
|
Immunome, Inc.
|
US
|
NASDAQ
|
|
IMVT
|
Immunovant, Inc.
|
US
|
NASDAQ
|
|
IPHA
|
Innate Pharma S.A.
|
US
|
NASDAQ
|
|
IVVD
|
Invivyd, Inc.
|
US
|
NASDAQ
|
|
JNCE
|
Jounce Therapeutics, Inc.
|
US
|
NASDAQ
|
|
LXRX
|
Lexicon Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
MGNX
|
MacroGenics, Inc.
|
US
|
NASDAQ
|
|
MRSN
|
Mersana Therapeutics, Inc.
|
US
|
NASDAQ
|
|
MRUS
|
Merus N.V.
|
US
|
NASDAQ
|
|
NGM
|
NGM Biopharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
OABI
|
OmniAb, Inc.
|
US
|
NASDAQ
|
|
OTLK
|
Outlook Therapeutics, Inc.
|
US
|
NASDAQ
|
|
RCUS
|
Arcus Biosciences, Inc.
|
US
|
NYSE
|
|
REGN
|
Regeneron Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
SESN
|
Sesen Bio, Inc.
|
US
|
NASDAQ
|
|
SGEN
|
Seattle Genetics, Inc.
|
US
|
NASDAQ
|
|
TECH
|
Techne Corporation
|
US
|
NASDAQ
|
|
TGTX
|
TG Therapeutics, Inc.
|
US
|
NASDAQ
|